Q3 FY2024 · ended Sep 30, 2024 · Revenue $15,269, -96.4% YoY · Filed Nov 19, 2024
Can B Corp. (NASC) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In Q3 of fiscal 2024, the quarter ended Sep 30, 2024, it reported revenue of $15,269 and a net loss of $3.3 million.
Revenue
$15,269
-96.4% vs year-ago quarter
Net income
$-3.26M
+21.7% vs year-ago quarter
Operating cash flow
$9,098
+104.4% vs year-ago quarter
Free cash flow
$-206,626
+39.8% vs prior quarter
EPS
$-0.05
+86.1% vs year-ago quarter
Dividend per share
None
Shares outstanding
75.84M
+189.0% vs year-ago quarter
Net cash
$-124,097
Q1 FY2024
Operating margin
-1035.9%
TTM
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- NASC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Hicksville, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1509957
- Former names
- Canbiola, Inc. (until Mar 3, 2020); Wrapmail, Inc. (until May 15, 2017)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2024 Sep 30, 2024 |
Q2 FY2024 Jun 30, 2024 |
Q1 FY2024 Mar 31, 2024 |
Q4 FY2023 Dec 31, 2023 |
Q3 FY2023 Sep 30, 2023 |
|---|---|---|---|---|---|
| Revenue | $15,269 | $272,287 | $369,096 | $376,889 | $418,957 |
| Operating income | -$2.8M | -$1.6M | -$5.7M | -$651,715 | -$3.6M |
| Net income | -$3.3M | -$2.0M | -$6.2M | -$1.8M | -$4.2M |
| Diluted EPS | -$0.05 | -$0.04 | -$0.16 | -$0.06 | -$0.36 |
| Operating cash flow | $9,098 | -$130,922 | $216,850 | $151,438 | -$206,626 |
| Free cash flow | — | — | — | — | -$206,626 |
| Total assets | $1.9M | $4.9M | $5.3M | $10.1M | $13.1M |
| Total liabilities | $11.6M | $11.1M | $10.4M | $12.0M | $12.9M |
| Stockholders' equity | -$9.8M | -$6.8M | -$5.3M | -$1.9M | $219,602 |
| Cash and investments | $7,879 | — | $26,582 | $34,006 | $31,318 |
| Total debt | — | $65,771 | $150,679 | $254,391 | $595,874 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Listing notice, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
|
Oct 28, 2024 | Oct 25, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | Jul 17, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Auditor change
|
May 31, 2024 | May 24, 2024 |
All 280 Can B Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.